Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 4c; Boosts FY13 Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Myriad Genetics, Inc. (MYGN) Tops Q1 EPS by 4c; Boosts FY13 Outlook

Jefferies Raises Numbers on Myriad Genetics (MYGN)

November 6, 2012 12:54 PM EST

Jefferies maintained a Buy rating on Myriad Genetics (NASDAQ: MYGN) and raised its price target to $33.00 (from $31.00). Myriad recently reported earnings that were ahead of consensus, and as a result analysts raised EPS estimates on the diagnostics company.

"We expect... More